Nimotuzumab combined with chemoradiotherapy for the treatment of cervical cancer: A meta-analysis of randomized controlled trials

OBJECTIVES: To assess the clinical efficacy and toxicity of nimotuzumab in combination with chemoradiotherapy or chemoradiotherapy alone in the treatment of cervical cancer. METHODS: The PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure, China Biomedical Medic...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Yan, Chen, Jiuzhou, Fang, Miao, Guo, Yaru, Sun, Xueqing, Yu, Dehong, Guo, Yilong, Xin, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573994/
https://www.ncbi.nlm.nih.gov/pubmed/36263226
http://dx.doi.org/10.3389/fonc.2022.994726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573994/
https://www.ncbi.nlm.nih.gov/pubmed/36263226
http://dx.doi.org/10.3389/fonc.2022.994726

Ejemplares similares